Genmab
🇩🇰Denmark
Clinical Trial of HuMax-CD4, a New Drug to Treat Advanced Stage T-Cell Lymphoma in the Skin.
- First Posted Date
- 2003-10-15
- Last Posted Date
- 2023-04-28
- Lead Sponsor
- Genmab
- Target Recruit Count
- 22
- Registration Number
- NCT00071084
- Locations
- 🇺🇸
Stanford University Med Ctr., Dept of Dermatology, Stanford, California, United States
🇺🇸University of Texas, M.D. Anderson Cancer Center, Houston, Texas, United States
Trial With HuMax-CD4 in Participants With Rheumatoid Arthritis (RA) Failing Treatment With Methotrexate (MTX) and a TNF-alpha Blocker
- First Posted Date
- 2002-08-01
- Last Posted Date
- 2023-04-28
- Lead Sponsor
- Genmab
- Target Recruit Count
- 83
- Registration Number
- NCT00042406
- Locations
- 🇺🇸
Rheumatology Associates, Montgomery, Alabama, United States
🇺🇸Pro Health Partners, Inc., Long Beach, California, United States
🇺🇸Rheumatology & Internal Medicine, Boling Clinical Trials, Rancho Cucamonga, California, United States